Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: John H. Farro who wrote (3899)	9/17/1998 11:43:00 PM
From: John H. Farro	Respond to of 4342

Folks, I just got the Nutraceutical News article off of PRLN's web site. You might want to visit it. If you click on "PRLN in the News" you will see a lengthy article by Colin Campbell and Bernie Landes. I haven't had a chance to read it yet, but I'm sure it will provide very informative and pleasureable reading over the weekend. I really liked what I read in the Nutraceutical News article. Robin

To: John H. Farro who wrote (3899)	9/18/1998 12:25:00 PM
From: Elllk	Respond to of 4342

Robin Interesting article. There have may a few attacks in the media, current one after NE J of Medicine study attacking alternative and supplement/herbal treatments. In addition to the issue of intended biological activity of supplements the NE J Med points out problems of harmful fillers and additives adding toxicity to herbal, etc, tablets. Since PRLN has the technology to determine toxicity of many things this should also be something examined in the BioFit analysis. And this is exactly what the supplement field needs, at this point, for quality in both of these respects to be certified. Especially since it does appear, from recent escalation of attacks, that the AMA, etc., is making a concerted effort against supplements/alternative treatments, etc. Larry